Lataa...
Inhibition of lymphangiogenesis in vitro and in vivo by the multikinase inhibitor nintedanib
PURPOSE: To investigate the feasibility of nintedanib, a novel triple angiokinase inhibitor, for inhibiting lymphatic endothelial cell (LEC)-induced lymphangiogenesis in vitro and inflammatory corneal lymphangiogenesis in vivo. MATERIALS AND METHODS: Methylthiazolyldiphenyl-tetrazolium bromide (MTT)...
Tallennettuna:
| Julkaisussa: | Drug Des Devel Ther |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5391212/ https://ncbi.nlm.nih.gov/pubmed/28435226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S130297 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|